STOCK TITAN

Arvinas to Present Virtually at the Goldman Sachs 41st Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

On June 5, 2020, Arvinas (Nasdaq: ARVN) announced Dr. Ron Peck, Chief Medical Officer, will speak at the Goldman Sachs 41st Annual Global Healthcare Conference on June 11 at 4:40 p.m. ET. A live audio webcast will be available here and on their website at www.arvinas.com.

Positive
  • None.
Negative
  • None.

NEW HAVEN, Conn., June 05, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ron Peck, M.D., Chief Medical Officer, will participate in a fireside chat at the Goldman Sachs 41st  Annual Global Healthcare Conference on Thursday, June 11 at 4:40 p.m. ET.

A live audio webcast of the presentation will be available here and on the Company’s website at www.arvinas.com. A replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.

About Arvinas
Arvinas is a clinical-stage biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. The company has two clinical-stage programs: ARV-110 for the treatment of men with metastatic castrate-resistant prostate cancer; and ARV-471 for the treatment of patients with locally advanced or metastatic ER+/HER2- breast cancer. For more information, visit www.arvinas.com.

Contacts for Arvinas

Investors
Will O’Connor, Stern Investor Relations
ir@arvinas.com

Media
Kirsten Owens, Arvinas Communications
kirsten.owens@arvinas.com


FAQ

When will Arvinas participate in the Goldman Sachs Healthcare Conference?

Arvinas will participate in the Goldman Sachs 41st Annual Global Healthcare Conference on June 11, 2020, at 4:40 p.m. ET.

Who is representing Arvinas at the Goldman Sachs Healthcare Conference?

Dr. Ron Peck, Chief Medical Officer of Arvinas, will represent the company.

How can I access the Arvinas presentation at the conference?

A live audio webcast of the presentation can be accessed here and on Arvinas' official website.

Will there be a replay of the Arvinas presentation?

Yes, a replay of the webcast will be archived on the Arvinas website for 30 days following the presentation.

Arvinas

NASDAQ:ARVN

ARVN Rankings

ARVN Latest News

ARVN Stock Data

1.19B
62.69M
7.22%
110.23%
14.21%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN